An Early Enteral Nutrition Protocol in Shanghai

NCT ID: NCT03216993

Last Updated: 2018-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-01

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

compare different enteral nutrition strategy in patients with mechanical ventilation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There has been many evidence that deficiency in energy and protein take-in are associated with poor outcome in critical patients. To reach an adequate amount of energy and protein is critical in patients with respiratory failure and with mechanical ventilation, as it prevents muscle dystrophy and thus prevents ICU acquired weakness, leading to a better outcome in the end. Enteral Nutrition is preferred as it prevents gut dysfunction in respiratory failure patients, and may prevent further infection. But there are many challenge in implement a good enteral nutrition therapy, and energy or protein deficiency is common in patient with respiratory failure. There have been many protocols aiming at reaching enough enteral nutrition for ICU patients, most of which are based on a background of western and developed countries. The investigators developped a enteral nutrition protocol based on an unique cultural background of eastern developing country, trying to help the ICU patients reaching nutrition target, so that the patients may have better outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Enteral Feeding Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care

Standard care: patients receive enteral nutrition in accordance with the usual practice in the participating units

Group Type OTHER

Standard care

Intervention Type OTHER

Standard care: patients receive enteral nutrition in accordance with the usual practice in the participating units

Protocol care

Protocol care: patient receive enteral nutrition in accordance with enteral nutrition protocol studied

Group Type EXPERIMENTAL

Protocol care

Intervention Type OTHER

Protocol care: patient receive enteral nutrition in accordance with enteral nutrition protocol studied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard care

Standard care: patients receive enteral nutrition in accordance with the usual practice in the participating units

Intervention Type OTHER

Protocol care

Protocol care: patient receive enteral nutrition in accordance with enteral nutrition protocol studied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ICU patients
* Receiving mechanical ventilation (MV) both Non-invasive ventilation and invasive ventilation
* Expecting MV more than 72 hours

Exclusion Criteria

* Pregnancy
* ICU stay \< 72hr
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ruijin Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Erzhen Chen

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhen Er Chen, Doctor

Role: STUDY_CHAIR

Ruijin Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ruijin

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hongping Qu, Doctor

Role: CONTACT

+8618917762330

Ming Zhong, Master

Role: CONTACT

+8613564626325

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Shanghai EEN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.